Hamamatsu Corporation is the North American subsidiary of Hamamatsu Photonics K.K. (Japan), a leading manufacturer of devices for the generation and measurement of infrared, visible, and ultraviolet light, as well as X-rays. These devices include photodiodes, silicon photomultipliers, photodiode arrays (image sensors), infrared detectors, ion detectors, photomultiplier tubes, scientific light sources, and modular spectrometers. The parent company is dedicated to the advancement of photonics through extensive research. This corporate philosophy results in state-of-the-art products which are used throughout the world in scientific, industrial, and commercial applications.
Hamamatsu provides high performance components for analytical instruments. These components include detectors and light sources for use in UV-vis, NIR, Raman, TOF-MS, and other spectrometers. We also provide modular spectrometers for medical and biological research, environmental monitoring, production and process control, semiconductor inspection, chromatography, food analysis, water content measurement, and other industries.
Hamamatsu Corporation has its headquarters in Bridgewater, New Jersey. In addition, engineers are located in offices throughout the US to provide technical and sales support.
Hamamatsu Corporation
360 Foothill Road
Bridgewater, NJ 08807
TELEPHONE
(908) 231-0960
FAX
(908) 231-1539
E-MAILusa@hamamatsu.com
WEB SITEwww.hamamatsu.com
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.